BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10506840)

  • 1. [Severe cholestasis with kidney failure from anabolic steroids in a body builder].
    Habscheid W; Abele U; Dahm HH
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1029-32. PubMed ID: 10506840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgenic/Anabolic steroid-induced toxic hepatitis.
    Stimac D; Milić S; Dintinjana RD; Kovac D; Ristić S
    J Clin Gastroenterol; 2002 Oct; 35(4):350-2. PubMed ID: 12352300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholestasis in young men after taking anabolic steroids].
    Elsharkawy AM; McPherson S; Masson S; Burt A; Dawson RT; Hudson M
    Praxis (Bern 1994); 2012 May; 101(10):661-4. PubMed ID: 22565557
    [No Abstract]   [Full Text] [Related]  

  • 4. Stanozolol-induced bland cholestasis.
    Ampuero J; García ES; Lorenzo MM; Calle R; Ferrero P; Gómez MR
    Gastroenterol Hepatol; 2014 Feb; 37(2):71-2. PubMed ID: 24360796
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe intrahepatic cholestasis and liver failure after stanozolol usage - case report and review of the literature.
    Stępień PM; Reczko K; Wieczorek A; Zarębska-Michaluk D; Pabjan P; Król T; Kryczka W
    Clin Exp Hepatol; 2015 May; 1(1):30-33. PubMed ID: 28856252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At what price, glory? Severe cholestasis and acute renal failure in an athlete abusing stanozolol.
    Yoshida EM; Karim MA; Shaikh JF; Soos JG; Erb SR
    CMAJ; 1994 Sep; 151(6):791-3. PubMed ID: 8087755
    [No Abstract]   [Full Text] [Related]  

  • 7. Bile cast nephropathy due to cholestatic jaundice after using stanozolol in 2 amateur bodybuilders.
    Tabatabaee SM; Elahi R; Savaj S
    Iran J Kidney Dis; 2015 Jul; 9(4):331-4. PubMed ID: 26174462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone).
    Lehmann S; Thomas A; Schiwy-Bochat KH; Geyer H; Thevis M; Glenewinkel F; Rothschild MA; Andresen-Streichert H; Juebner M
    Forensic Sci Int; 2019 Oct; 303():109925. PubMed ID: 31499423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenprocoumon-induced cholestatic hepatitis].
    Woolley S; Burger HR; Zellweger U
    Dtsch Med Wochenschr; 1995 Nov; 120(44):1507-10. PubMed ID: 7588020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatotoxicity of anabolic steroids].
    Rozman C; Urbano A; Galera H
    Minerva Med; 1971 Jun; 62(51):2605-11. PubMed ID: 5566874
    [No Abstract]   [Full Text] [Related]  

  • 11. Clenbuterol and anabolic steroids: a previously unreported cause of myocardial infarction with normal coronary arteriograms.
    Goldstein DR; Dobbs T; Krull B; Plumb VJ
    South Med J; 1998 Aug; 91(8):780-4. PubMed ID: 9715231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestasis secondary to anabolic steroid use in young men.
    Elsharkawy AM; McPherson S; Masson S; Burt AD; Dawson RT; Hudson M
    BMJ; 2012 Feb; 344():e468. PubMed ID: 22302781
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement.
    Singh V; Rudraraju M; Carey EJ; Byrne TJ; Vargas HE; Williams JE; Balan V; Douglas DD; Rakela J
    J Clin Gastroenterol; 2009 Mar; 43(3):287. PubMed ID: 18813027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cholestatic jaundice and pruritus].
    Stocker C; Hardmeier B; Looser M; Scharf C; Greminger P
    Praxis (Bern 1994); 2002 Sep; 91(38):1561-4. PubMed ID: 12369223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A jaundiced bodybuilder Cholestatic hepatitis as side effect of injectable anabolic-androgenic steroids.
    Boks MN; Tiebosch AT; van der Waaij LA
    J Sports Sci; 2017 Nov; 35(22):2262-2264. PubMed ID: 27937337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute bile nephropathy secondary to anabolic steroids.
    Alkhunaizi AM; ElTigani MA; Rabah RS; Nasr SH
    Clin Nephrol; 2016 Feb; 85(2):121-6. PubMed ID: 26587777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic agents: clinical efficacy versus side effects.
    Moldawer M
    J Am Med Womens Assoc; 1968 Apr; 23(4):352-69. PubMed ID: 4231505
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatatis in growth promoter treated cows.
    Groot MJ
    J Vet Med A Physiol Pathol Clin Med; 2002 Nov; 49(9):466-9. PubMed ID: 12489869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity of stanozolol in cats.
    Harkin KR; Cowan LA; Andrews GA; Basaraba RJ; Fischer JR; DeBowes LJ; Roush JK; Guglielmino ML; Kirk CA
    J Am Vet Med Assoc; 2000 Sep; 217(5):681-4. PubMed ID: 10976299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilated cardiomyopathy and acute liver injury associated with combined use of ephedra, gamma-hydroxybutyrate, and anabolic steroids.
    Clark BM; Schofield RS
    Pharmacotherapy; 2005 May; 25(5):756-61. PubMed ID: 15899737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.